← Back

Positrigo 🇨🇭

Series B
Company site ↗

Ultra-compact brain PET scanner for accessible dementia and Alzheimer's diagnosis. Zurich.

About Positrigo

Positrigo's main product is an ultra-compact brain Positron Emission Tomography (PET) system designed for functional brain imaging, particularly for diagnosing dementia and Alzheimer's disease. The technology aims to provide precision medicine and make functional imaging more accessible and affordable, utilizing advanced imaging techniques to enhance diagnostic capabilities for various brain-related disorders.

Positrigo is a Switzerland-based company founded in 2018, now around 28 people.

Founded by Jannis Fischer (Co-Founder & CEO; previously NORD/LB; International Institute for Management Development), Max Ludwig Ahnen (Chief Science Officer (CSO) emeritus - Advisory Board; previously ETHZ; International Institute for Management Development).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Positrigo? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series B · Oct 2025

InvestorsHealthCap
  • HealthCap — HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996.
Raising your own round? See which European funds fit →